FAILURE OF NALTREXONE TO AFFECT THE PLEASANTNESS OR INTAKE OF FOOD

被引:33
作者
HETHERINGTON, MM
VERVAET, N
BLASS, E
ROLLS, BJ
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT & BEHAV SCI,MEYER 1-108,BALTIMORE,MD 21205
[2] UNIV DUNDEE,DEPT PSYCHOL,DUNDEE DD1 4HN,SCOTLAND
[3] AGR UNIV WAGENINGEN,DEPT HUMAN NUTR,6700 HB WAGENINGEN,NETHERLANDS
[4] CORNELL UNIV,DEPT PSYCHOL,ITHACA,NY 14853
[5] JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT & BEHAV SCI,BALTIMORE,MD 21205
关键词
HUNGER; NALTREXONE; SENSORY-SPECIFIC SATIETY; FOOD INTAKE; FULLNESS; OPIOID ANTAGONISTS; HEDONICS; EATING BEHAVIOR;
D O I
10.1016/0091-3057(91)90343-Z
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Two separate studies were conducted to investigate the effects of oral naltrexone on the pleasantness ratings of foods and food intake. In both studies, normal-weight, nondieting males rated hunger, fullness, mood and the pleasantness of the taste of a variety of foods before and after double-blind administration of 50 mg of naltrexone or placebo. All subjects received a test meal, in a counterbalanced, repeated measures design. In the first study, 12 subjects were given a self-selection test meal after overnight deprivation. In the second study 14 subjects were given an ice cream test meal with no deprivation. In both experiments the pleasantness of the taste of the foods, sensory-specific satiety, hunger ratings and overall energy intake were not differentially influenced by naltrexone administration. In Experiment 2, intake of the ice cream was greater after active drug administration because subjects who received active drug on the first session ate less ice cream in the placebo session. In conclusion, in the short term, naltrexone had no impact on hunger, sensory-specific satiety or food intake.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 30 条
[1]   NALOXONE DECREASES FOOD-INTAKE IN OBESE HUMANS [J].
ATKINSON, RL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (01) :196-198
[2]   EFFECTS OF LONG-TERM THERAPY WITH NALTREXONE ON BODY-WEIGHT IN OBESITY [J].
ATKINSON, RL ;
BERKE, LK ;
DRAKE, CR ;
BIBBS, ML ;
WILLIAMS, FL ;
KAISER, DL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) :419-422
[3]  
ATKINSON RL, 1987, FASEB J, V46, P178
[4]  
BRAY GA, 1985, NAASO NOTES 0503
[5]   NALOXONE REDUCES FOOD-INTAKE IN HUMANS [J].
COHEN, MR ;
COHEN, RM ;
PICKAR, D ;
MURPHY, DL .
PSYCHOSOMATIC MEDICINE, 1985, 47 (02) :132-138
[6]  
DREWNOWSKI A, 1989, 142ND AM PSYCH ASS A, P207
[7]   AN OPIOID ANTAGONIST, NALTREXONE, REDUCES PREFERENCE FOR SUCROSE IN HUMANS [J].
FANTINO, M ;
HOSOTTE, J ;
APFELBAUM, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (01) :R91-R96
[8]   EATING ATTITUDES TEST - INDEX OF THE SYMPTOMS OF ANOREXIA-NERVOSA [J].
GARNER, DM ;
GARFINKEL, PE .
PSYCHOLOGICAL MEDICINE, 1979, 9 (02) :273-279
[9]   SCALED VERSION OF THE GENERAL HEALTH QUESTIONNAIRE [J].
GOLDBERG, DP ;
HILLIER, VF .
PSYCHOLOGICAL MEDICINE, 1979, 9 (01) :139-145
[10]   NALTREXONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF OPIOID DEPENDENCE [J].
GONZALEZ, JP ;
BROGDEN, RN .
DRUGS, 1988, 35 (03) :192-213